Anatomy of an IPO: The story of how Johnson & Johnson went public
We trace the company’s 130-year evolution from a small operation with 14 employees to its IPO 75 years ago this month to its current standing as a forward-thinking healthcare leader.
In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.
In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
